Vascular Solutions (NASDAQ: VASC) and Sequenom (NASDAQ:SQNM) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitabiliy, valuation and dividends.

Institutional & Insider Ownership

80.2% of Vascular Solutions shares are held by institutional investors. Comparatively, 46.0% of Sequenom shares are held by institutional investors. 6.9% of Vascular Solutions shares are held by insiders. Comparatively, 3.1% of Sequenom shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Vascular Solutions and Sequenom’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vascular Solutions 13.02% 15.78% 14.30%
Sequenom -21.54% N/A -25.05%

Risk and Volatility

Vascular Solutions has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Sequenom has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Vascular Solutions and Sequenom, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vascular Solutions 0 4 0 0 2.00
Sequenom 0 0 0 0 N/A

Vascular Solutions presently has a consensus price target of $55.50, suggesting a potential downside of 0.89%. Given Vascular Solutions’ higher probable upside, equities analysts clearly believe Vascular Solutions is more favorable than Sequenom.

Valuation & Earnings

This table compares Vascular Solutions and Sequenom’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Vascular Solutions N/A N/A N/A $0.70 80.00
Sequenom N/A N/A N/A ($0.34) -7.03

Sequenom is trading at a lower price-to-earnings ratio than Vascular Solutions, indicating that it is currently the more affordable of the two stocks.

Summary

Vascular Solutions beats Sequenom on 7 of the 8 factors compared between the two stocks.

Vascular Solutions Company Profile

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Sequenom Company Profile

Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company’s diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories’ test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Receive News & Stock Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related stocks with our FREE daily email newsletter.